血小板衍生外泌体通过减轻软骨退变和软骨下骨丢失缓解膝骨关节炎
该研究为对照实验室研究,评估血小板衍生外泌体(Plt-exos)对骨关节炎(OA)的作用及分子机制。体外实验显示Plt-exos呈剂量依赖性促进软骨细胞增殖和迁移,体内小鼠前交叉韧带切断OA模型每周关节腔注射Plt-exos一次共6周后,软骨再生改善、胫骨软骨下骨异常重塑减轻,OA进展减缓。
要点
- 体外实验显示Plt-exos呈剂量依赖性促进人原代软骨细胞增殖和迁移。
- 小鼠OA模型中每周关节腔注射Plt-exos一次共6周,减轻软骨退变和软骨下骨丢失。
- RNA测序显示Plt-exos处理后软骨细胞1797个基因差异表达(923上调、874下调)。
核心结论
- Plt-exos在体外促进软骨细胞增殖和迁移,在体内减轻软骨退变、改善软骨下骨微结构并延缓OA进展。
- 作者认为Plt-exos可能通过减轻软骨退变和软骨下骨丢失缓解膝OA,未来可能成为OA的新型有前景治疗。
研究设计与样本
- 对照实验室研究(controlled laboratory study)。
- 体外:分离鉴定人单采血小板来源外泌体,在白细胞介素1β刺激下评估对人原代软骨细胞增殖和迁移的影响,并进行RNA测序。
- 体内:采用前交叉韧带切断构建OA小鼠模型,关节腔注射Plt-exos每周一次共6周,末次注射后4周处死小鼠。
主要发现
- Plt-exos呈剂量依赖性显著促进软骨细胞增殖和迁移。
- Plt-exos显著促进软骨再生并减轻胫骨软骨下骨异常重塑,从而减缓OA进展。
- Plt-exos处理后软骨细胞中1797个基因差异表达,其中923个上调、874个下调。
- 功能富集结果和枢纽基因主要涉及抗炎作用、介导细胞黏附、刺激软骨修复、促进合成代谢和抑制分解代谢。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteoarthritis (OA) is the most prevalent chronic degenerative joint disease among the aged population. However, current treatments for OA are limited to alleviating symptoms, with no therapies that prevent and regenerate cartilage deterioration. PURPOSE: To assess the effects of platelet-derived exosomes (Plt-exos) on OA and then to explore the potential molecular mechanism. STUDY DESIGN: Controlled laboratory study. METHODS: Exosomes derived from human apheresis platelets were isolated and identified. The effects of Plt-exos in protecting chondrocytes under interleukin 1β stimulation were evaluated by analyzing the proliferation and migration in human primary chondrocytes. RNA sequencing was later performed in vitro for primary chondrocytes to reveal the underlying mechanisms of Plt-exo treatment. Anterior cruciate ligament transection was used to construct an OA mice model, and intra-articular injection of Plt-exos was given once a week for 6 weeks. Mice were sacrificed 4 weeks after the last injection. Histologic and immunohistochemistry staining and micro-computed tomography analysis were performed to assess alterations of articular cartilage and subchondral bone. RESULTS: Plt-exos significantly promoted proliferation and migration of chondrocytes within a dose-dependent manner, as well as dramatically promoted cartilage regeneration and attenuated abnormal tibial subchondral bone remodeling, thus slowing the progression of OA. After being treated with Plt-exos, 1797 genes were differentially expressed in chondrocytes (923 upregulated and 874 downregulated genes). Functional enrichment results and hub genes were mainly involved in anti-inflammatory effects, mediating cell adhesion, stimulating cartilage repair, promoting anabolism, and inhibiting catabolism. CONCLUSION: Our results demonstrated that Plt-exos promoted chondrocyte proliferation and migration in vitro, as well as attenuated cartilage degeneration, improved the microarchitecture of subchondral bone, and retarded OA progression in vivo. CLINICAL RELEVANCE: Our study illustrated that the administered Plt-exos could alleviate knee OA by attenuating cartilage degeneration and subchondral bone loss, possibly serving as a novel promising treatment for OA in the future.
引用
- Xu C, Mi Z, Dong Z, et al. Platelet-Derived Exosomes Alleviate Knee Osteoarthritis by Attenuating Cartilage Degeneration and Subchondral Bone Loss. Am J Sports Med. 2023. PMID: 37551685. doi:10.1177/03635465231188122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。